Prospective NIPT Sample Collection Protocol

Brief description of study

The purpose of this study is to collect blood samples from volunteers to develop a new noninvasive prenatal test, that can detect these genetic abnormalities in blood samples. The intended clinical benefit of the new test is to provide physicians and laboratories with a test that provides an opportunity for early detection of these genetic abnormalities without harming the fetus or the pregnant mother. This test is still being developed and validated and is not Food and Drug Administration (FDA) approved for clinical use.

Clinical Study Identifier: s21-01262

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.